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INTRODUCTION AND STATEMENT OF PROBLEM 
For the last 17 years, it has been known that when tes-
tosterone was administered to mammals increased quantities of 
etiocholanolone and androsterone appeared in the urine (18,19). 
Experiments with labeled testosterone have indicated that these 
steroids isolated from the urine are direct metabolites of 
testosterone. Where the transformation of testosterone takes 
place in the body of the animal, or the- mechanism by which it 
is converted into these metabolites, has not been completely 
solved. 
These products may be the result of either of two different 
processes. In order to maintain a constant internal environ-
ment, the organism must reduce, remove, or destroy the high 
physiological activity of excess testosterone, or the physio-
logical action of the hormone may be associated with its 
conversion to these metabolites. To gain a better understand~ 
ing of the mechanism by which testosterone is metabolized, a 
number of experimental approaches have been used. They are 
(a) implanting pellets of the hormone at different sites in 
the body of a castrated animal and then assessing androgenic 
potency by the response of the secondary sex organs, (b) per-
fusing an organ or organs with a medium containing the androgen, 
and then isolating the steroids formed, and (c) incubating 
tissue slices, minces, homogenates, and preparations of cellular 
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components with the androgen, and then rinding the metabolites 
producedo 
An attempt was made by Samuels, et a1. (1) to ascertain 
the role of the liver in testosterone metabolism. They incu-
bated microgram amounts of the steroid, which were completely 
soluble in the medium used, with liver tissue. Sweat and 
Samuels (2) concluded that testosterone was probably catabolized 
by two dirferent routes. One route was activated by DPN and led 
to the rormation of A4-androstene-3,l7-dione while the other one 
was activated by citrate and did not rorm 17-ketosteroids. It 
was shown by Levedahl and Samuels (3) that methyltestosterone 
was metabolized by the route activated by citrate, which de-
stroyed the a-~ unsaturation of ring A, but not by the route 
activated by DPN which oxidized the hydroxyl group at Carbon 17. 
The purpose of this investigation was to study further the 
liver system activated by citrate which destroyed the a-~ unsatu-
ration of ring A 0 Since methyltestosterone was metabolized by 
this system but not by the one oxidizing the 17 position~ it was 
chosen primarily as the substrate. 
HISTORICAL 
I. Metabolism or Testosterone: 
Androgen biochemistry could be said to have begun with the 
work of McGee (4). He prepared lipid extracts from bull testis 
which would consistently cause a resumption of growth of a 
capon's comb. Earlier work by Berthold (5) had shown that 
testis transplants would minimize the effects ot castration, 
and Loewy (6) indioated that injections of testicular substance 
caused comb growth in young capons. However, it was the 
preparation of an active extract of testis by McGee (4) that 
started a wave of investigations which culminated in the 
crystallization of a highly potent androgen from bull testis 
by David et a1. (7). These authors named the crystalline 
material testosterone. Its structure was established as 
A4-androstene-17~-ol-3-one when it was synthesized by Ruzicka 
et a1. (8) and Butenandt and Hanisch (9) from cholesterol. 
From the time of its isolation, testosterone was oonsidered 
to be the naturally occurring male hormone even though it had 
not been isolated from the blood stream. In 1952, West et ale 
(10) succeeded in isolating it rrom the spermatic vein blood 
or dogs. At the present time, the evidence indicates that it 
is the natural male hormone because (a) it is the most active 
naturally occurring androgen found (11), (b) it has been iso-
lated from testis (7)(12), (c) it has been isolated from 
-3-
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spermatic vein blood in greater amounts than could be present 
in peripheral blood (10), and (d) it can be synthesized by 
testis tissue (13)(14). 
Not long after the isolation and characterization of 
testosterone it was found that an increase in urinary androgens 
accompanied its administration (15)(16)(17). Callow (18) and 
~rnman et ale (19) were able to isolate increased amounts of 
etiocholanolone and androsterone from the urine of patients 
receiving large doses of testosterone. Later Dorfman (20) 
isolated androstane-3~-ol-17-one from the urine of a hypo-
gonadal male given testosterone therapy. 
Deuterium labeled testosterone was injected into a normal 
man by Gallagher et ale (21) and the urinary metabolites were 
measured. Androsterone and etiocholanolone were found to be 
the major metabolites, but small quantities of androstane-), 
17-dione and etiocho1ane-3,17-dione were also present. Only 
39 per cent of the injected dose was recovered. 
Fukushima et alo (22) compared the metabolitee excreted 
and the percentage of administered dose recovered after a 
100 mg. and a 10 mg. injection of deuterium labeled testosterone 
into normal men. The same labeled steroids reported by Gallagher 
(21) were isolated. No difference was observed in the ratio of 
the metabolites excreted; the recovery of the dose administered 
was 49 per cent of the 10 mg. and 39 per cent of the 100 mg. 
injection. A difference was noted in the excretion pattern of 
individuals. One subject produced predominately etiocholanolone 
-5-
while the others produced predominantly androsterone. 
The same group of investigators (23) then infused 16 mg. 
of testosterone-d-4-C14 over a period of 4 hours into a normal 
man and were able to recover 60 per cent of the dose. West 
et ale (24) were able to recover 74 per cent of a dose of 
250 mg. testosterone infused into a normal man. This is the 
best recovery yet reported. 
Mammals other than man have been given testosterone and 
the products excreted in the urine determined. Dorfman and 
Fish (25) injected testosterone propionate into guinea pigs 
and were able to isolate androstane-3~-ol-one. The same 
workers (26) also isolated etiocholanolone, androsterone, and 
A4-androstene-3,17-dione from the urine of chimpanzees receiving 
testosterone propionate. Monkeys may also produce androsterone 
when they are given testosterone, as was shown by Horwitt et ale 
(27). 
The experiments just mentioned indicate that the major end 
products of testosterone metabolism are androsterone and etio-
cholanolone but give no hint as to where this transformation 
takes place or the conditions accompanying it. Evidence that 
the liver is involved first came from Biskind and Mark (28). 
Pellets of testosterone implanted into the spleen were much 
less effective in stimulating the prostate and seminal vesicles 
of a castrated rat than were those implanted subcutaneously. 
Burrill and Green (29) showed that a testis transplanted into 
the spleen was not 80 effective in promoting the growth of the 
-6. 
prostate and seminal vesicles of a castrated rat as was one 
transplanted subcutaneouslye Beoause the venous drainage of 
the spleen goes into the portal system, the liver was considered 
to be the site of inactivation. 
Patients with cirrhosis of the liver have been shown by 
West et ale (24) to excrete only one third as much 17-keto-
steroids as normal individuals during testosterone administra-
tion. This finding indioates that the liver plays a role in 
the formation of 17-ketosteroidae 
Clark and Kochakian (30)(31) first demonstrated that the 
liver could metabolize testosterone in vitro. After incubating 
the hormone with rabbit liver slioes, they were able to isolate 
mostly unohanged testosterone~ but some A4-androstene-3,17-dione 
and small amounts of 17-epitestoBterone were present. 
In order to detect what products had been formed from the 
incubation, Clark and Kochakian (31) had to use a greater 
quantity of testosterone than would dissolve in the inoubation 
medium used; therefore, the question arose whether or not the 
liver slioes would have acted on smaller amounts of the hormone 
and if the same products would have been produced. 
The measurement of the metabolism of testosterone after 
incubation of quantities which would remain in solution in the 
aqueous medium was made possible b7 the development of a method 
whereby microgram qu·antities of the steroid could be determined 
(32). Utilizing the absorption at 240 ~ of the a-~ unsaturated 
ketone in ring A and the Koenig reaction (33)" the amount of 
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destruction of testosterone could be detected, and by an 
adaptation of the Zimmermann (34) reaction the formation of a 
17-ketone could be determined. 
By the application of this method, Samuel. et ale (1) were 
able to show that liver from the rat, mouse, rabbit, and human 
was able to destroy the a-~ unsaturated ketonic structure or 
testosterone while rabbit uterus, rat prostate and seminal 
veaicles, and mouse mammary tissue were inactive. The reaction 
could be inhibited by boiling, or by cyanides iodoacetate, 
flouride, malonate, or an atmosphere of nitrogen. 
Later work by Samuels et ale (35) indicated that livers of 
birds and mammals destroyed the a-~ unsaturation of ring A of 
testosterone and also produced 17-ketosteroids, while livers 
from fish, amphibians, and reptiles destroyed the a-~ unsatu-
ration at a slow rate but did not form 17-ketosteroids. Dog 
kidney seemed to be about one-eighth as active as rat liver 
()6) in destroying the conjugated system of ring A. 
Sweat and Samuels (2) then presented evidenee that rat 
liver catabolized testosterone by two different routes. One 
required DPN and formed 17-ketosteroids while the other was 
activated by citrate and did not form 17-ketoateroid.. Later, 
Sweat et ale (37) were able to purify partially an enzyme from 
l1ver that formed A4-androstene-3,17-dione from testosterone. 
The change that takes place in ring A of testosterone during 
incubation with liver tissue remained to be determined. 
-8-
II. Metabolism of Methyltestosterone: 
During the same year in which they had synthesized testos-
terone, Ruzicka et a1. (38) prepared l7a-methyltestosterone and 
found it to be androgenical1y active. Soon after its preparation 
this synthetic steroid was reported to be more effective orally 
than testosterone in rats (39) and humans (40). The reason for 
the greater comparative activity of methyltestosterone when 
administered by mouth is not yet known. However, some differ-
ences have been noted in the metabolism of the two steroids. 
No increase in androgenic material or in l7-ketasteroids 
has been found in the urine of animals receiving methyltestos-
terone (41)(42)(43), while the urine of those receiving 
testosterone contains greater quantities of both androgenie 
material and 17-ketosteroids. Even though the difference in 
metabolism of the two steroids has been apparent for some time, 
the chemical nature of the compounds excreted when methyl-
testosterone is catabolized has not been determined. 
Again the liver seems to be a site for the catabolism of 
this steroid. Biskind (44), using the same implanting technique 
with which he studied testosterone, found methyltestosterone to 
be inactivated when it was absorbed into the portal system. 
Burrill and Greene (45) then compared the inactivation of 
methyltestosterone with testosterone when the two steroids were 
implanted into the,apleens af animalao These auth@ra came to 
the conclusion that the liver had a greater capacity to in-
activate testosterone than methyltestosterone. 
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In view of the inactivation that takes place in the liver, 
Hyde et a1. (46) thought that the difference between ~e oral 
effectiveness of the steroids might be due to the absorption 
of methyltestosterone through the 1actea1s, thereby bypassing 
the liver. To test their proposal, they administered 17a-c14-
methyltestosterone intragastrica1y to rats and measured the 
amount of radioactivity entering the thoracic duct. Only 1.5 
per cent entered by this route. It appears, therefore, that 
methyltestosterone is absorbed primarily into the portal vein 
and that the difference in oral effectiveness between the 
androgens is not due to a different route of absorption. 
Levedahl and Samuels (3) have comp~ed the metabolism of 
testosterone and methJlt •• tosterone by incubating them with 
t . 
liver slices from dog, rat, chicken, guinea pig, monkey, rabbit, 
and human. The conjugated system of ring A of both steroids 
was destroyed by all the species listed, while 17-ketosteroida 
were produced only from testosterone. When DPN was added to 
the incubation mixture, with testosterone as substrate, an 
increased formation of l7-ketosteroids as well as an increased 
destruction of the a-~ conjugated system of ring A was noted. 
No activation of the destruction of methyltestosterone was 
observed in the presence of the co-enzyme. However, the 
addition of citrate to the incubation medium caused an increased 
destruction of the a-~ unsaturation of both steroid •• 
-10-
III. Metabolism of the A Ring of Progesterone: 
Venning and Browne (47) were the first to show that 
increased amounts of pregnanediol glucuronide appeared in the 
urine of women after they had been given progesterone. Since 
then, men (48), hysterectomized women (49){50), and rabbits 
(51)C52) have been shown to excrete pregnane-3a,20a-diol after 
treatment with progesterone. In addition to pregnanediol, small 
amounts of pregnane-3a-ol-20-one from a diabetic man (53) and 
allopregnane-3a,20a-diol from women (54) have been isolated 
following progesterone administration. 
Like testosterone, only a small amount of the administered 
dose of progesterone has been recovered. Sommerville and 
Marrian (55), using intramuscular injections of progesterone in 
oil found that they could recover only 9 to 16 per cent as 
pregnanediol. A slightly better recovery was obtained by 
Gallagher (56) when he administered progesterone-4-c14 to 
women. He was able to isolate 30 per cent of the radioactivity 
in the urine. 
The destruction of progesterone in the body of an animal 
was first observed by Zondek (57). He found that 48 hours after 
injection no progesterone could be detected in an extract of the 
whole body of the animal when decidual formation in the uterus 
of immature rabbits was used as the assay, but he did not 
determine where the destruction took place. 
By pellet implantation (58)(59) and by injection of pro-
gesterone directly into the portal vein (60), the liver has been 
I 
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implicated as a site for the inactivation of this hormone. 
In vitro experiments have also demonstrated that liver 
tissue is capable of catabolizing progesterone. Samuels (36) 
reported that the conjugated system of ring A of progesterone 
was destroyed when it was incubated with rat liver mince. 
Later, Wiswell and Samuels (61) confirmed this finding with 
broken cell preparations. The destruction could be accelerated 
by the addition of citrate, iaocitrate, cis-aconitate, cysteine, 
and cyanide, but not by DPN. They also observed no inhibition 
when a nitrogen atmosphere was used during the incubation. 
Because of the activation shown when metal binding agents are 
present, it was concluded that the enzyme system is inhibited 
by metal ions. 
Taylor (62) was able to confirm the findings of Wiswell 
and Samuels (61) except that he reported an activation of 
destruction on the addition of DPN. He also isolated allo-
pregnane-3,20-dione and allopregnane-3a-ol-20-one as metabo-
lites of the incubation. 
By incubating large quantities of progesterone with rat 
liver slices, Horwitt and Segaloff (63) were able to isolate 
and identify pregnane-3a,20a-diol. 
Later, Taylor (64) incubated a series of flasks containing 
microgram quantities of progesterone with rabbit liver homogen-
ates and then isolated the steroids from the pooled extracts of 
the incubation mixture. Pregnane-3a,20a-diol and pregnane-3a-
01-20-one were present in the greatest concentration, then came 
-12-
unchanged progesterone followed by allopregnane-3 a - ol-20-one. 
allopregnane-3~20-dione, and allopregnane-3~-ol-20-one. 
IV. Metaboli'sm of the A Ring of the Corticoids. 
Cuyler et ale (65) first reported that pregnane-3a,20a-diol 
was excreted in increased amounts in the urine after the adminis-
tration of II-desoxycorticosterone to a normal man. However, 
they were unable to confirm their original findings when both 
men and women were given desoxycorticosterone (66)(67). Later~ 
Horwitt et ale (68) found increased amounts of pregnanediol in 
the urine of 3 men and 1 woman receiving desoxycorticosterone 
therapy. Rabbits and chimpanzees (69) have also been shown to 
excrete increased quantities of pregnanediol in their urine 
after they had been given desoxycorticosterone. 
The major end product of II-dehydrocorticosterone metabolism 
in man was round by Mason (70) to be pregnane-3a~20a-diol-ll-one. 
After giving corticosterone to a patient with rheumatoid 
arthritis, Engel et ale (7l) were able to isolate allopregnane-
3a,11~,21-triol-20-one~ pregnane-3a~11~~21-triol-20-one~ preg-
nane-3a~21-diol-ll,20-dione~ and pregnane-3a~20a-diol-ll-one 
from the urine. 
Both cortisone acetate and cortisol acetate were given to 
men by Burstein et ale (72)(73) and the excretion products 
determined. From both steroids the major metabolites were 
pregnane-3aJ17a,21-triol-ll~20-dione and etiocholane-3aJll~­
diol-17-one. Pregnane-3a~11~~17a,2l-tetrol-20-one and 
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etiocholane-3a-ol-ll,17-dione, as well as cortisol and cortisone, 
were also present in increased amounts. 
When the guinea pig was given cortisol, no products were 
isolated which had been reduced in ring A, although the 20-ketone 
had been reduced and a 6-~-hydroxyl group had been added (74). 
It appears that ring A of all the corticoids studied is 
reduced during their metabolism in man and all ather mammals 
tested except the guinea pig. Whether or not the guinea pig ia 
unique in. its treatment of cortisol will be resolved only by 
further investigation. 
Using the same method by which they implicated the liver 
in the catabolism of testosterone and methyltestosterone, 
Burrill and Greene (75) showed that pellets of desoxycorti-
costerone were inactivated when they were implanted intra-
mesenterically. 
Nelson and Harding (76) injected cortisone into dogs and 
then determined the 17-hydroxysteroids in arterial and venous 
blood samples taken from various places in the body. Marked 
differences were shown between the arterial and heptic venous 
samples. No significant arterio-venous differences were found 
when samples were taken across other tissues. It, therefore, 
seems that the liver is playing a major role in metabolizing 
the corticoids. 
In vitrG perfusions of rat livers with both cortisone and 
cortisol by Capsi et ale (77)(78) have indicated that the liver 
is capable of catabolizing these steroids to a variety of 
-14-




21-triol-3,11-dione and androsterone were isolated. All five 
of the products found from the perfusion with cortisol-4-c14 





Schneider and Horstmann (79) have incubated desoxycorti-
costerone with rat liver slices and mince. In 3 hours 35 
per cent of the a-~ unsaturation of ring A and 25 per cent of 
the side chain were destroyed. The enzyme system was active 
under a nitrogen gas phase and was not activated by citrate. 
Kidney slices were about one third as effective as liver slices 
in destroying the conjugated system of ring A but fully as 
active in degrading the side chain. Diaphragm segments were 
about one fourth as active in destroying both ends of the 
molecule while adrenal halves did not degrade the side chain 
but showed some destruction of the conjugated system. Later 
Schneider (80) identified allopregnane-3a,a-diol-20-one, a110-
pregnane-3~,21-diol-20-one, allopregnane-21-o1-3,20-dione, and 
allopregnane-3a-20,21-triol as products of the incubation. 
These same workers (8l) then incubated Il-dehydrocorti-
-15-
costerone , cortisone, cortisol, and Il-desoxy-17-hydroxy-
corticosterone with liver slices. A destruction of both the 
side chain and the a-~ unsaturated system of ring A was noted 
in all of the steroids. The best substrate used was II-dehydro-
corticosterone while the worst was Il-desoxy-17-hydroxycorti-
costerone. When cortisone was incubated with different tissues, 
liver slices were found to be more active than kidney slices, 
diaphragm segments, adrenal homogenate, heart slices, or rectus 
abdominus muscle mince. 
Recently Forchielli et ale (82) incubated a supernatant, 
prepared from rat liver by centrifuging a homogenate at 600 x g. 
for 30 minutes, with Il-desoxy-17-hydroxycorticosterone. The 




The most extensive study of the systems in liver which 
catabolize ring A was done by Tomkins and Isselbacher (8)(84) 
(85), with cortisone and cortisol as substrates. After ultra-
ce,ntrifugation of a rat liver homogenate, the supernatant would 
catalyze the formation of pregnane-3u , 17a,2l-triol-ll,20-dione 
from cortisone. Further purification of the enzyme system by 
ammonium sulfate fractionation and calcium phosphate gel adsorp-
tion permitted the identification of the first step of the 
reaction sequence as the saturation of the double bond at posi-
tion 4. This reduction is a specific one in regard to both the 
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cofactor required and the product formed. Only TPNH is active, 
and only the S~ configuration is obtained. With further puri-
fication of the enzyme, they found that only cortisone was 
reduced. They concluded that different enzymes catalyze the 
reduction of the double bond in ring A of cortisone, cortisol, 
and adrenosterone. 
Tomkins, (86) also obtained a purified enzyme from liver 
that catalyzed the reduction of the ketone at position 3. Both 
019 and C2l steroids as well as those with the 5~ and Sa con-
figuration were reduced; however, the 5~ compounds were much 
better substrates. The carbonyl group at 017 was not changed 
and neither was the 3 carbonyl of the C27 steroids. In addition, 
the 3 hydroxyl formed always had the a configuration. 
IN SUMMARY, it appears that the A4-3-ketone of ring A, 
which is present in all of the nonbenzenoid steroid hormones, is 
preferentially reduced before the steroid skeleton is excreted 
from the bodies of mammals. There may be mammals which do not 
catabolize ring A of some of the hormones; thus far the guinea 
pig recei ving cortis 01 is the one except ion noted. Of all the 
tissues investigated, the liver contains the most active system 
for the destruction of the a-13 unsaturation of ring A. 
A comparison of the products excreted after testosterone 
administration with those produced from the hormone by the liver 
cannot be made at the present time. Since the compounds formed 
when the conjugated system of ring A is destroyed have not been 
identified, one can only speculate whether these steroids have 
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the same stereo-configuration as those excreted. 
The synthetic androgen l1a-methyltestosterone is also in-
activated by the liver and it appears to be catabolized by the 
same system which destroys the a-~ unsaturation of testosterone. 
When the excreted metabolite of progesterone is compared to 
th~se formed during incubation with liver, a close parallel is 
found. Pregnane-3a,20a-diol is the major product of each trans-
formation. At least in the case of progesterone, the liver is 
capable of forming the excreted end product of its metabolismo 
An apparent discrepancy is found when the products arising 
from metabolism of the corticoids in vivo and in vitro are 
compared. All of the compounds isolated from the in vivo 
experiments, excepting one, had the pregnane nucleus. In both 
perfusions and incubations where large amounts of steroids were 
incubated with liver preparations, the only products isolated 
that had a reduced ring A contained the allopregnane nucleus. 
A different picture is obtained, however; when the 'amount of 
steroid incubated resembles more closely physiological concen-
trations l and a purified enzyme preparation is used. When 
cortisone is incubated under these conditions, only the pregnane 
nucleus is isolated and this is in agreement with the products 
excreted from a normal man given the same steroid. 
EXPERIMENTAL METHODS 
I. Tissue Preparation: 
Rat liver was used as the source of enzyme throughout this 
study. Male albino rats (Spr.ague-Dawley strain) ranging from 
130 to 420 grams were decapitated with a sharp knife. Their 
livers were quickly excised and placed in a beaker surrounded 
by crushed ice. The livers were kept chilled until they could 
be cut into pieces about 1 cm. squAre just prior to homogeniza-
tion. After the addition of 25to 75 mI. of phosphate buffer 
containing 0.02 to 0.08 molar niacinamide, the liver tissue was 
disintegrated. During the initial phase of this problem a Ten 
Broeck (87) hand homogenizer was used. Later, a 'Polytron l 
high frequency homogenizer" made by Max Wullimann, Selzach, 
Switzerland" was employed. Approximately 3 minutes were 
required for complete homogenization, after which enough buffer 
was added to the homogenate to give a final concentration of 
2 mI. of buffer for every gram of tissue. This preparation was 
then stored at 30 C. until centrifuged. 
For forces up to 20,000 x gravity, the homogenate was 
centrifuged at 00 C. in an International refrigerated centrifuge, 
model PH-I, with the high speed head No. 269. When 100,000 x go 
was required, a Spinco preparative ultracentrifuge model L with 
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1. Ammonium Sulfate Fractionation and Dialysis: 
The usual material for this state of purification was 
either fraction S2 alone or both fractions S2 and R20 Solid 
ammonium sulfate was added slowly with constant stirringo 
After the crystals had dissolved, the mixture was allowed to 
stand for 5 minutes at 50 e., then the precipitate which had 
formed was sedimented at 20,000 x g. for 10 minutes. To 
determine the amount of ammonium sulfate needed, the formula 
derived by Kunitz (88) was used. 
The precipitates were dissolved in a minimum amount of 
bufrer and placed in "Visking" cellulose sausage casings which 
~ . 
had been presoaked in distilled water for 30 minutes (Manurac-
tured by the Visklng Corporation, Chicago, Ill.). Each of the 
bags was attached to an apparatus which rotated in a beaker 
containing the dialysis medium. This procedure shortened the 
dialysis time and conserved burfer. During the dialysis period, 
which was from 12 to 16 hours, three 4-1iter portions of water 
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or buffer were used. When water was used as the dialysis 
medium, a precipitate formed. To redissolve the precipitate, 
buffer was added and the mixture was stirred at room temperature 
for 5 minutes, then centrifuged for 10 minutes at 20,000 x g. 
The supernatant solution was then incubated as such or used as 
starting material for further purification. 
2. Calcium Phosphate Gel Adsorption: 
Calcium phosphate gel was prepared as described by Keilin 
and Hartree (89). It wa.s allowed to age three weeks or more 
before use. In the majority of experiments the solution to 
which calcium phosphate gel was added was adjusted so that the 
nitrogen concentration was 3.4 mg. per mI. Then the required 
amount of the gel (calculated on its dry weight) was added and 
the mixture thoroughly stirred until an even distribution of 
the solid was observed. This mixing required about 15 minutes. 
The mixture was then centrifuged for 10 minutes at 20,000 x g. 
If further adsorptions were desired, additional quantities of 
C83(P04)2 gel were added to the supernatant solution and the 
above procedure was repeatedo No attempt was made to adjust 
the nitrogen concentration or volume of the supernatants on 
subsequent additions of the gel. In order to elute the protein, 
a volume of 0.1 N phosphate buffer at the desired pH, equal to 
the volume of the final supernatant obtained, was added to the 
gel and thoroughly mixed as described aboveo The suspension 
was then centrifuged for 10 minutes at 20,000 x g. 
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3. Ethanolic Fractionation: 
To a solution containing the enzyme kept in an ice bath at 
0 0 e., absolute ethanol, kept at a _10 0 e., was added dropwise. 
The solution was stirred continuously to avoid a high concen-
tration of ethanol in anyone portion. When the desired amount 
of ethanol had been adde~ the solution was allowed to remain at 
-50 to 100 C. for 10 minutes. To collect the precipitate which 
had formed, the solution was then centrifuged for 10 minutes at 
o 20,000 x g. and -10 C. After centrifugation the supernatant 
o ' 
s61ution was cooled to -10 e., and the cold ethanol was again 
added until the desired concentration ensued. This solution 
was let stand, and then centrifuged according to the above 
procedure. The residues obtained from the centrifugations were 
quickly dissolved in a minimum amount of cooled phosphate buffer" 
and stored in the refrigerator at 30 c. 
Nitrogen Determination 
The nitrogen concentration of samples was determined by a 
slight modification of the microkjeldahl procedure of Perrin 
rII. Buffers, Cofactors, and Substrates: 
The buffers used in this work are as follows: 
Krebs phosphosaline buffer containing 0.04M NaH2P04 + 
Na2HP04' pH 7.4, 0.0056M KCl, 0.0021M MgC12' 
0.08M NaCl, p.nd O.OOIM sodium citrate. 
Tria (tris [hydroxymethyl] aminomethane) buffer, 
0.04M, pH 7.4 with the same concentrations of 
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KC1, MgC12 , NaC1, and citrates as the phosphate 
buffer. 
Krebs-Ringer bicarbonate buffer composed of 0.155M 
NaC1, 0.033M NaHC03' 0.0061M KCL, 0.0029M MgS04' 
0.0033M CaC12 , 0.0018M KH2P04' having a pH of 
7·4· 
The following cofactors and substrates were obtained as 
listed: 
Diphosphopyridine nucleotide (DPN). Pabst, 92% pure. 
Reduced diphosphopyridine nucleotide (DPNH). Sigma, 
Purity unknown. 
Reduced triphosphopyridine nucleotide (TPNH). 
Sigma, 90% pure. 
17a-methy1testosterone. Ciba 
17a-methy1testosterone-20-c14. Ciba, 2 x 105 cpm. 
per t,LM. 
Epi testosterone. eiba Mp. 216;-2200 • 
Dihydrotestosterone. Ciba Mp. 180-1820 • 
17a-ethy1testosterone. eiba MP. 138.2-139.50 • 
Testosterone. Syntex Mp. 155-155.50 • 
Testosterone-4-c14• Tracerlab. 1. 
44 -androstene-17-amino-3-one. Ciba 
Progesterone. Stock solution. 
44-androstene-3-one. eiba 
44-androstene-3,17-dione. Stock solution. 
When DPN, DPNH, and TPNH were used, they were added in 
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concentrations of 0.4 millimolar. In most of the incubations 
the cofactor solution was a boiled liver extract. This extract 
was prepared by boiling sma.ll chunks of liver in the phosphate 
buffer for approximately 10 minutes, homogenizing the mixture, 
and then centrifuging it at 20,000 x g. for 20 minutes. The 
supernatant solution was then added to the incubation mixture. 
Most samples received an amount of extract equivalent to 0.5 
gram liver. 
The cofactors and substrates were used as they were obtained 
without further purification. 
IV. Incubation Techniques: 
The required amount of steroid dissolved in ethanol was 
added to a 125 ml., glass-stoppered, Erlenmeyer flask. The 
flask was then placed under an air jet and the ethanol was 
evaporated. Just before the buffer and cofactor solutions were 
added to the flask, 0.2 mI. of absolute ethanol was introduced 
to redissolve the steroid and enhance its solubility in the 
aqueous solution. Initially the final volume per flask was 
25 ml. Later it was changed to 20 ml., and then to· 10 ml. 
Buffer and cofactor solutions were than added. The enzyme 
fraction was pipetted into the flask and nitrogen gas or a 
mixture of 95 per cent oxygen and 5 per cent carbon dioxide Was 
blown over the surface of the liquid. When the 02-C02 mixture 
was used the flasks were gassed for 5 minutes. In most experi-
merits where nitrogen was used, the gas was bubbled through the 
buffer for 20 minutes before it was added to the flask. When 
this had been done, the flask was gassed for 5 minutes. If it 
had not been done, 10 minute periods were used. 
At the end of the gassing period, the flasks were stoppered 
and sealed. A mixture formed from heating equal weights of rosin 
and beeswax together was applied to the top of the ground portion 
of a heated glass stopper and the stopper was put in the flask 
while still warm. Ten minutes later the stopper was taped on the 
top of the flask with adhesive tape and the flask was clamped to 
a rotating spindle in a constant temperature bath. The flask was 
then rotated at a desired temperature for the required length of 
time. 
When the incubation period was over, the flask was removed 
from the bath, unstoppered, and the contents boiled after the 
addition of 3 drops of octanol, or the stoppered flask was 
placed in a deep freezer. 
v. Steroid Ext~action and Purificationa 
The contents of the incubation flasks were transferred to 
100 mI. centrifuge tubes after the sealing material had been 
removed from the ground j oint wi th benzene ol!:ach flask WGS 
then rinsed thoroughly with three 6-ml. portions of ethyl 
acetate and added to the centrifuge tubes. A propeller-tipped 
stirring rod attached to an electric motor was used to mix the 
organic and aqueous phases which were then separated by centri-
fugation. When the separation of the phases was complete, the 
ethyl acetate was transferred to 125 mI. Erlenmeyer flasks with 
a "serum lifter". This procedure was repeated twice wi th 20-mlo 
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portions of ethyl acetate. The extracts from each sample were 
then combined and the ethyl acetate was removed by evaporation 
under a jet of air. 
Modified Zaffaroni (91) paper chromatograms were used to 
purify the ethyl acetate extract. Strips of Whatman No.2 filter 
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The strip was then immersed in a methanol-formamide 
mixture (1:1), blotted, and hung at room temperature until the 
methanol had evaporated. At the end of this time, the residue 
from the ethyl acetate extraction was applied to the origin of 
the chromatogram and the chromatogram was put in a glass jar 
saturated with Skellysolve 'rC' (Commercial Petroleum distillate 
composed mainly of heptane). 
After a development of 6 hours with Skellysolve C. the 
paper chromatogram was removed from the tank, dried, and 
examined under ultraviolet light to locate steroids having the 
a-~ unsaturation in ring A. This time of development was usually 
sufficient to elute the fat from the end of the strip. The strip 
was then placed in another glass jar and developed with dichloro-
ethane overnight. A graduated glass-stoppered test tube was 
placed below the strip to catch the eluate. Approximately 5 mI. 
of eluate were collected. The sides of the tube were rinsed 
with ethanol and the tube was placed under an air jet to increase 
the evaporation of the solvents. 
A small drop of liquid, presumably formamide, remained in 
the bottom of the tube after the dichloroethane and the ethanol 
had evaporated. To eliminate this material, 2 mI. of distilled 
water were added to the tube and the aqueous phase was extracted 
twice with 4 mI. portions of dichloroethane. The tube contain-
ing the extract was then placed under an air jet until the di-
chloroethane had evaporated. By this pro~edure, a sample was 
obtained that gave good symmetrical absorption curves with little 
interferring background in the ultraviolet spectrum from 2200 ~ 
o 
to 2600 A. 
During the latter part of this work when the incubations 
contained a purified enzyme fraction and no niacinamide, it was 
possible to determine the absorption pattern of the ethyl 
acetate extract without further purification. 
The recovery of steroid from a sample boiled immediately 
after the addition of the enzyme fraction and then carried 
through the arume procedure as the other samples was about 84 
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per cent with a homogenate and 95 to 104 per cent with all of 
the other enzyme fractions. 
VI. Quantitative Estimations of Steroids. 
To determine the amount of a-~ unsaturation in a sample, 
1.0 mI. of ethanol was added to the residue and the solution 
was left standing for 1 hour. An aliquot was transferred to a 
"Cary" recording spectrophotometer cell and diluted with ethanol 
until the cell held a final volume of 3.2 mI. The ultraviolet 
o 
absorption pattern of the sample was then read between 2200 A 
and 2600 X against a blank which had been carried throu~h the 
same steps as the sample from the time of incubation. If any 
material having a-~ unsaturation was present in the sample, a 
o 
curve with a maximum around 2400 A appeared. Quantification 
of such a curve was obtained by the following equations: (92) 
o 0 0 (a) 2 x OoD. at 2400 A - (O.D. at 2300 A+O.D. at 2500 A=A 
(b) A of sample x quantity of standard x A of standard 
Total volume of sample ::;: quantity of material in 
Volume of aliquot srumple 
The ketone group at C-3 was quantitatively determined by 
the method of Gornall and MacDonald (93). In this method the 
2,4-dinitrophenylhydrazone is formed in an acidic methanol 
solution; then the solution is made basic to enhance and 
stabilize the color. The brownish red has a maximum absorption 
at 435 m~. 
Paper partition chromatography was used to separate the 
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steroids extracted from the incubation medium. The systems used 
were those described by Bush (94). In his system, the material 
to be chromatographed is applied to a dry untreated strip of 
filter paper. The strip is then placed in a jar having an 
atmosphere saturated with the solvents used to develop the 
chromatogram, until saturation of the paper is complete. When 
this situation (equilibration) has been achieved, the developing 
solvent is added to the trough inside the jar through a hole 
drilled in the plate glass top and allowed to flow over the 
paper for the required time. 
Sheets of Whatman No.2 filter paper, 23 inches square, 
were cut into 7-inch strips, the maximum width which the glass 
jars used would accommodate. These strips were than divided 
into a number of lanes as illustrated (Fig. 2). It was found 
I~ 23" 
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that 300 micrograms of steroid would move in a compact zone 
without trailing when applied to a 3-inch lane of paper. Lanes 
ranging from 1 cm. to 7 inches were used with good results. On 
the outer lanes at the origin, a small amount of Sudan III dye 
was applied. This served as a visual gauge of the extent of 
movement of solvent. When the dye spot was about 6 cm. to B cm. 
from the bottom of the strip, the paper was removed from the jar 
and dried at 370 c. 
The developing solvents used in this work were: 
(a) Skellysolve C methanol: water, 85:15 (by 
volume) i (des ignated hereafter as C-85) . 
(b) Benzene: Skellyso1ve C 33:66, saturated with 
methanol: water, 80:20 (by volume); (designated 
hereafter as Bc-BO) 
(c) Benzene saturated with methanol: water, 55:45 
(by volume); (designated hereafter as B-55) 
When the extracts chromatographed were fairly clean and 
contained very little fat, an equilibration time of 6 hours 
was sufr"icient. For cruder extracts an equilibration of from 
12 to 16 hours was required. At the end of this time, the 
solvents were added to the troughs and the chromatogram was 
allowed to develop. 
In order to detect the steroid on the paper, general color 
reactions, specific color reactions, measurement of radioactivity, 
and ultraviolet light absorption were used. An ultraviolet light 
scanner, modeled after the one described by Haines and Drake (95), 
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was used to locate the steroids having the a-~; unsaturation of 
ring A. The dark areas were encircled with a line drawn by a 
graphite lead pencil. 
When C14-labeled steroids were chromatographed, the radio-
active zones were found by cutting a 2 cm. strip from the lane, 
then dividing this into 2 cm. squares and counting each square 
in a windowless proportional counter. By knowing the consecu-
tive arrangement of the squares which had formed the strip, the 
R 's of the radioactive zones could be calculated. Later, when 
f 
a strip counter was available, a recorded pattern of the radio-
activity on a strip 2 cm. wide was made during the passage of 
the strip through the counter equipped with a thin window. 
An 8 per cent solution of phosphomo'iybdic acid in absolute 
ethanol was used to detect 114 -uns~'turated-3-ones, ei ther A4 or 
A5 unsaturated diols, and 17a-methylandrostane-3a,17~-diol 
(Androstane-3a, 17~-dio'1 did not react wi th this reagent). A 
blue spot appeared where the steroid was located when the 
paper was sprayed with the reagent and set in a room with a 
temperature of 370 c. for 15 minutes. 
Saturated steroids containing ketone groups were found by 
applying a saturated solution of 2,4-dinitrophenylhydrazine in 
2N aqueous Hel. 
A fairly specific reagent for A4 and A5 unsaturated 3-018 
was a 15 per cent solution of phosphotungstic acid in absolute 
ethanol. Of all the compounds tried, the only ones that pro-
duced a purplish-red color ware those having one of these 
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configurations. It was also possible to distinguish between 
A4 and A5 3-01s, since the 65 compounds gave a color containing 
more red than the A4 compounds. 
Three methods were used to elute the steroids from the paper. 
In the first method, ethanol was drawn from a trough by capillary 
action onto the paper strip containing the steroid zone and allowed 
to drip into a container from the slightly pointed end of the 
paper. In the second method, a paper containing a steroid zone 
was placed in a Soxhlet apparatus and refluxed for 3 hours with 
ethanol. The third method consisted of cutting the paper con-
taining the steroid zone into 1 em. or smaller squares, then 
letting the squares sit for 15 minutes in a beaker containing 
1 mI. ethanol per square centimeter of paper. At the end of 
this time the ethanol was removed with a pipette. The pro-
cedure was repeated twice more, the 3 portions of ethanol were 
combined and the solvent evaporated under an air jet. 
Usually steroids eluted by the first and third methods were 
sufficiently purified to give a good symmetrical absorption 
o 0 
curve in the spectral region from 2200 A to 2600 A. In case 
further purification was desired, the eluted material was dis-
solved in 5 mI. of dichloroethane and applied to a silica gel 
column 5 cm. high and approximately 0.7 cm. in diameter. The 
'steroids were then eluted from the column with 0.7 per cent 
ethanol in dichloroethane. 
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VII. Preparation of' l7a.-methylandrostene-3a.,17(3-diol and 
l7a.-methylandrostene-3~,17(3-diol: 
To 1.0 gram of methyltestosterone dissolved in a minimum 
of absolute methanol, 90 mg_ of NaBH4was added with continuous 
stirring. When the bubbling stopped, distilled water was added 
to the reaction mixture. The white crystalline precipitate 
formed was filtered of'f and washed with water until the filtrate 
had the same pH as the water. The aqueous filtrate was ex-
tracted with three 25-ml. portions of ethyl ether which were 
combined, and washed with 10 mI. of' O.lN HCl and then with water 
until neutral. Vmen the ether was evaporated the residue (about 
10 mg.) was added to the collected precipitate which had been 
dried at room temperature. 
A solution of' 3.23 gm. digitonin in 450 mI. 90 per cent 
ethanol was prepared, and 250 mI. of this was added to an 
ethanolic solution of the crystalline reaction products. After 
standing for two days at room temperature, the digitonlde which 
had precipitated was collected and the volume of the filtrate 
concentrated to 150 mI. by heating to 450 Co under reduced 
pressure. To this concentrated filtrate was added the remaining 
digitonin solution and the mixture was again allowed to remain 
at room temperature for 2 days, af'ter which time the precipitated 
digitonide was collected. The combined digitonide f'ractions 
weighed 1.0628 grams. 
A minimum amount of pyridine was used to dissolve and split 
the digitonideo The digitonin was preCipitated by the addition 
-33-
of ether and filtered off. The ether solution was washed with 
dilute Hel and then water, dried over sodium sulfate, and 
evaporated to dryness. The amount of crude 17a-methyl-A4-
androstene-3~,17~-diol obtained was 178 mg. 
The volume of the filtrate, remaining from the digitonide 
collections, was reduced close to dryness, extracted with three 
50-mI. portions of ethyl ether, and the extract was filtered. 
The ether was evaporated to dryness leaving a residue of crude 
17a-methYl-l14-androstene-3a,"17~-diOl, weighing 445 mg. 
After 3 recrystallizations from acetone, the melting point 
of the 17a-methYI-A4-androstene-3a,17~-diOl was 1700 to 1720 Co~ 
and that of the 17a-methYI-A4-androstene-3~,17~-diol was 1580 
to 159.50 c. 
VIII. Reactions Used to Identify Steroids: 
1. Preparation of Acetates: 
Acetylation was used both as a means of determining the 
presence of unhindered alcohol groups, and for the specific 
identification of steroid alcohols. Approximately 30 ~ge of 
the material to be acetylated was dried for two days in a 
vacuum desiccatoro One drop of acetic anhydride and one drop 
of pyridine were then added and thoroughly mixed. When the 
solution had stood at room temperature for 24 hours, 3 mI. of 
water were added and the mixture was extracted with two 5-ml. 
portions of ether. The combined ether extracts were then 
washed with dilute H2S04' dilute NaOH, and water, dried over 
Na2s04' filtered and evaporated. 
2. Oppenauer Oxidatio~~ 
The Oppenauer oxidation was employed to c ompnpe the metabo-
lite with the methylandrostenediol and to check for the presenc·e 
of the ~4 or A5 3-01 grouping. Aluminum isopropoxide (8 mgo9 
Eas tman) was added to approximately 75 \.Lg. of the material to 
be oxidized which was dissolved in 3 mI. of acetone and 5 mI. 
of benzene. The mixture was then refluxed for 12 hourso T'o 
the cooled reaction medium, 2 mI. of 2N HCl were added and the 
phases were well mixed. The benzene layer wns then removed 
f.lnd washed wi th water, fil tered through B. small amount of 
Na2so4' and evaporated to dryness. 
3. Preparation of Thiosemictlrba,zones~ 
The presence B.nd position of a ketone group was determ.ined 
by the ultraviolet absorption spectrum of the thiosemicarbazoneso 
Thiosemicarbazones were prepBred by a slight modification of the 
procedure described by Bush (96). To a ground glass .... stoppered 
tube holding approximately 15 p,g. of steroid in 0.1 mI. of 
ethanol was added 001 mI. of glacial acetic anhydride containing 
5 mg. per mI. of thiosemicarbazide. After the stopper had been 
o 
taped on the tube .. the sample WHS he ated at 100 Ce for 1+0 
minutes. After the tube had cooled, the solution was mnde up to 
0.3 mI. with ethanol, and transferred to a microspectrophoto-
metric cell. The absorption spectrum from 200 ~. to 320 ~o 
\vas the n recorded. 
4. Radioactive Counting Technigues~ 
The radioactive maasul"»ements were accomplished by counting 
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aliquots of solutions and paper strips containing the radio-
active compound. Material in solution was plated on aluminum 
discs. During the process of plating, the disc was mounted on 
an electrically driven turntable and rotated while a stream of 
air was directed on it to enhance the evaporation of the solvent. 
In order to control the solution flow so that an equal distribu-
tion of the radioactive material was obtained, a fine-tipped 
pipette attached to a small syringe was used. 
Most of the plating was done with ethanol as the solvent. 
When amounts of crystalline material of 3 mg. or more were 
plated on each disc, a more even distribution was achieved by 
using 70 per cent aqueous methanol. Both the aluminum discs 
and the paper squares previously referred to were counted with 
a gas flow counter. 
5. RecrystallizatLon to Constant Specific Activity: 
To determine if the radioactive material waS the same as 
the carrier employed, the mixture was recrystallized a number 
of times to see if a constant specific activity was attained. 
A portion of the radioactive material was added to a compound 
with which it was assumed to be identical. The mixture was 
then recrystallized, the radioactivity of the crystals determined, 
and the specific activ~ty (CPM/mg.) calculated. After a second 
recrystallization and calculation of the specific activity, the 
first and second specific activities were compared. If they 
were different, then more recrystallizations were performed 
until the specific activity between two consecutive recrystalli-
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zations was the same or until it was apparent that a constant 
speciric activity would not be achieved. When two consecutive 
recrystallizations produced a constant speciric activity, it 
was assumed that the crystallization pattern and structure or 
both compounds were the same; thererore, one criterion or 
identity had been satisried, and the carrier was considered to 
be the same as the radioactive component. When a constant 
speciric activity was not obtained, the recrystallization 
pattern or the two compounds was assumed to be dirrerentj 
thererore, the carrier was not considered to be the same as the 
radioactive component. 
6. Comparative Solubility Technique: 
The identicalness or a radioactive component and the com-
pound used as a carrier was checked by comparative solubilities. 
A procedure patterned arter that described by Gutman and Wood 
(97) was used. Approximately 20 mI. or material which had been 
recrystallized to a constant speciric activity was divided into 
two portions. The smaller portion contained approximately one 
third or the material. This portion was then incubated at a 
constant temperature in a volume or solvent in which it was 
not completely soluble, until equilibrium between solid and 
solution was obtained. An equilibrium was assumed when aliquots 
taken consecutively at 24-hour intervals showed the same amount 
or radioactivity per unit or solution. When this was,attained, 
the remaining two-thirds or the crystalline material was added 
to the solution. The mixture was again incubated until the same 
criterion or equilibrium had been achieved. rr the radioactive 
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material and the carrier were the same compound and true equi-
librium had been reached in each case, the radioactivity per 
unit volume of the solution should have been the same after the 
addition of the whole sample as after the addition of one third 
of the sample. If the two were different, the solution would 
not be expected to be saturated with the radioactive compound 
and more should dissolve. 
EXPERIMENTAL RESULTS 
I. Attempts to Identify Product From the Incubation of 
Methyltestosterone: 
The first step in determining the route by which methyl-
testosterone was metabolized was the identification of the 
first major product which accumulated in incubations with rat 
liver homogenate. One micromole of methyltestosterone was 
incubated for 1 hour at 36.5° C. with the quantity of homogenate 
prepared from 0.5 gme of rat liver. When the extract of the 
incubation medium was chromatographed in the 0-85 system, a 
spot was found moving behind methyltestosterone. The metabolite 
was detected by spraying the chromatogram with phosphomolybdic 
acid. No evidence of a-~ unsaturated was found upon examination 
of this area on the ultraviolet scanner. This spot was radio-
active when l7a-methYltestosterone-20-ol4 was incubated, indi-
cating it to be a metabolite of methyltestosterone. 
In order to find some evidence of the identity of this 
metabolite, all of the available l7-methylated steroids were 
chromatographed in the 0-85 system and the Rf values compared 
with that of the metabolite. Table I lists the Rr values of 
these compounds. From an examination of the table, it is 
obvious that the Rf of the metabolite did not agree with that 




COMPARISON OF THE Rf VALUES OF 17-METHYLATED STEROIDS 










Approximately 20 ~g. of steroid were applied to the origin 
of a strip 18 mm. wide. The strips were placed in tanks 
containing the c-85 system and equilibrated for 6 hours. 
They were then developed for approximately 4 1/2 hours. 
Spots were located by examination on an ultraviolet scanner 
and by spraying with phosphomolybdic acid. 
It is also apparent that the Rf values for methyltestoster-
one and 17a-methylandrostane-3a,17~-diol were the same within 
the limits of error of the measurement. To determine if there 
was a difference in the chromatographic behavior of these com-
pounds which was too small to measure after such a short dis-
tance of movement, the paper strips were developed for extended 
time periods. Approximately 20 hours were required for the 
separation of the two compounds. 
Since the metabolite moved more slowly than methyltestoster-
one and faster than 17a-methyl-~5-andr08tene-3a,17~-diOl, the 
assumption was made that it was more polar than methyltestosterone 
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and less polar than the 17a-methyl-A5-androstenediol. Because 
the movement was closer to the enediol than the snediol, it Was 
possible that it could be one of the l7a-methYl-A4-androstene-
diols. These compounds were not available commercially so they 
were synthesized. Both the 3a and the 3~ isomers of 17a-methyl-
d4-androstenediol had the same Hf value. Both gave a positive 
color reaction with phosphomolybdic acid. 
A comparison of the chromatographic movement of the metabo-
lite andthe 4a-methYl-A4-androstenediols showed them to be 
similar in this respect. The Hf values of the 17a-methyl-A4-
androstene-3a,17~-diol and the metabolite in Be-Bo system were 
0.39 and 0.41, respectively. When a mixture of radioactive 
metabolite and the diols was made and chromatographed, only one 
spot was observed. The blue color obtained with phosphomolybdic 
acid and the radioactivity were found in the same area. Since 
a difference of 0.02 in Hf values may be obtained with the same 
compound chromatographed in adjacent lanes, and because only 
one spot was noted in the lane containing the mixture, it 
appeared that one of the diols and the metabolite might be 
identical. 
To make a further comparison, the acetates of the metabo-
lite and the 3a and 3~ isomers of the methyl-A4-androstenediOI 
were compared and chromatographed in the O-B5 system. The 








The movements of the free compounds and the acetates 
indicated that the metabolite might be one of the methYl-~4-
androstenediols. Whether the metabolite had the 3a or the 3~ 
configuration could not be determined by chromatography in the 
two Bush systems since the movement of these two isomers was 
identical. In order to distinguish between these compounds, 
some of the radioactive metabolite was added to each of the 
diols and the specific activities of the crystals determined 
after a series of recrystallizations (Table II). A constant 
specific activity appeared to be attained after the second 
recrystallization when 17n-methYI-A4-androstene-3a,17~-diOI 
was the carrier while the specific activity of the 17a-methyl-
A4-androstene-3~,17~-diol was still decreasing after the third 
recrystallization. 
From the evidence presented, it appeared that the metabo-
lite was l7a-methyl-A4-androstene-3a,17~-diol. To test this 
conclusion, the constant solubility experiment described under 
Experimental Methods was performed. One third of a sample 
containing the mixture of r adioacti ve metabolite and l7a-methyl-
A4-androstene-3a,17~-diol that had been recrystallized to con-
stant specific activity was placed in a tube containing just 
enough 70-per cent methanol to dissolve all but a few crystals. 
The tube was placed vertically in a constant temperature bath 
with a shaking mechanism and incubated at 380 to 400 c. Ali-
quots of the solution were then plated and counted at 24-hour 
intervals until constant radioactivity was obtained. When this 
TABLE II 
RECRYSTALLIZATION OF THE RADIOACTIVE METABOLITE 












Radioactive metabolite was added to 11 mg. of 17a-me~hYl-~4-
androstene-3~,17~-diol and to 15 mg. of l7a-methyl-~4-andro­
stene-3a,11~-diol. Both compounds were recrystallized from 
warm acetone. Aliquots of the recrystallized materia.l were 
plated from 70-per cent methanol and counted. 
had been achieved the remaining' two-thirds of the sample was 
added to the tube and it was again incubated until the solution 
showed a constant radioactivity. The results of this experiment 
are shown in Table III. Since the radioactivity of the solution 
increased when a greater amount of compound was present, either 
the radioactive product was not the same as the carrier or 
equilibrium had not been achieved originally. In Experiment 
No.2 the tube was placed in the bath horizontally rather than 
vertically to increase the mixing and to enhance better equili-
bretion. The results obtained, however, were the same as those 
from Experiment No.1. It seemed unlikely that a similar degree 




CONSTANT SOLUBILITY OF RADIOACTIVE, METABOLITE 
CPM/ml. 
Exp. 1 Exp. 
Addition of 1/3 of sample 
675 540 1st aliquot 
2d aliquot 645 517 
Addition of remaining 2/3 of sample 
aliquot 914 826 
Ex~eriment No.1: 6.9 mg. of the radioactive metabolite 
and 17a-methYl-A4-androstene-3a,17~-diol which had been 
recrystallized to a constant specific activity was added 
to 2 mI. of 70-per cent aqueous methanol. First aliquot 
was taken 24 hours after addition and second aliquot 48 
hours after. The remaining 13.5 mg. were then added. 
Last aliquot was taken 48 hours after the addition of the 
larger portion. 
Ex~eriment No.2: 5.6 mg. was added to2 mI. 70-per cent 
me hanoI. Aliquots taken 24 and 48 hours after addition. 
11.3 mg. were then added. P1nal aliquot taken 48 hours 
after last addition. 
2 
The identity of the two compounds, therefore, was open to 
question in spite of their similar chromatographic behavior and 
their recrystallization to constant specific activity in one 
solvent system. To gain further evidence about the identicalness 
of the steroids, the absorption patterns of the sulfuric acid 
chromogens of both compounds were determined by the method of 
Zaffaroni (91). The metabolite gave two peaks with maxima at 
210 ~ and 387.5 ~ while the methylandrostenediol gave two 
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peaks wi th maxima at 310.5 ~ and 408 ~ 1 hour after the 
addition of the acid. When the samples were analyzed 2 hours 
and 4 hours after the acid had been added, a change was found 
in the optical densities but the maxima of the curves had not 
changed. The slight differences observed in the absorption 
spectra were not considered great enough to indicate whether 
or not the compounds were identical. 
An Oppenauer oxidation was then carried out on both com-
pounds, and the reaction products were c hromatographed in the 
Be-BO system. Figure III shows the results obtained. The 
oxidation of the methylandrostened1.o1 produces a compound that 
absorbs light in the ultraviolet region and moves the same 
distance as methyltestosterone, while the product isolated 
from the oxidation mixture of the metabolite moves the same 
distance and shows the same characteristics as the unchanged 
metabolite. Since the Oppenauer oxidation of ~4-3-01S and 
~5-3-ols has been shown to produce the ~4-3 ketone in ring A 
(98)" it appears that the metabolite contained neither of these 
configur at ionso 
Since it appeared that the two compounds were different~ 
a further attempt was made to separate them chromatographicallyo 
A mixture of the metabolite and 17a-methYl-64-androstene-3a,17~~ 
diol was chromatographed in the 0-85 system; a developing period 
of 13 hours was used rather than the normal of 4 1/2 hours. 
Figure IV illustrates that a separation of the compounds was 
possible when this increased time of development was employed$ 
17a.-methyl-
testosterone 
















metabolite GhosPhOmOlYb~ date positive No. u. V. 
Figure 3 - Chromatographic pattern of products 








Figure 4 - Chromatographic separation of metabolite 
and 17a-methYI-A4-androstene-3a,17~-diolo 
From the evidence obtained it was fairly well established 
that the metabolite was not 17a-methYI-A4-androstene-3a,17~-
diol even though the free compounds and acetates of both steroids 
chromatographed alike and the radioactive metabolite recrystal-
lized to a constant specific activity with the diol as the 
carrier when one solvent system was usedo 
The possible presenoe of a ketone group in the metabolite 
was ohecked with 2,4-dlnitrophenylhydrazlne and with thiosemi-
carbazide. When the hydrazine was added to a paper strip 
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containing a spot of the metabolite, no deeper yellow spot 
appeared. This finding indicated that a hydrazone had not been 
formed. When a reaction mixture containing thiosemicarbazide 
and the metabolite was subjected to ultraviolet absorption 
analysis, no curve having a maximum in the spectral region from 
260 ~ to 350 m~ WB.S obtained. Two compounds, dihydrotestoster'= 
one and androstnne-3-one, having ketone groups at 03' formed 
substances in the presence of thiosemicarbazide which absorbed 
ultraviolet light. Dihydrotestosterone produced a curve with 
a maximum at 318 ~ and androstane-3-one produced a curve with 
a maximum at 320 ~o Bush (96) claims that the curves given by 
thiosemicarbazones of saturated 17...,ketones show a maximum flt 
269 to 271 m~o Because no absorption curve having a maximum 
in either of the regions indicated was obtained with the metabo-
lite, it was concluded that the metabolite does not contain a 
ketone group at 03 or C17 0 Furthermore~ since neither a 2a4-
dinitrophenylhydrazone nor a thiosemicarbazone could be de-
tected, it was concluded tha t the metaboli te co ntained no 
ketone groups. 
Supporting evidence for the absence of a 114 or a 1.\5 gr'oup'"" 
ing in the metabolite was obtained by spraying paper strips 
containing the metabolite with phosphotungstic acid. The purple~ 
red color characteristic of these configurations did not appearo 
Instead 3 a dirty tan closely resembling that given by 17a~methyl~ 
androstane-3a,17~-diol appeared. Evidence for or against a Al 
grouping was not obtained. 
-48-
The metabolite appeared to be still a 020 steroid. When 
200,000 cpm. of 17a-methyltestosterone-20-014 were incubated 
with liver homogenate, 164,000 cpm., or 82 per cent was recovered. 
This recovery is in agreement with the 167.000 cpm. recovered 
from a sample containing 200,000 cpm. of methyltestosterone 
which had been boiled immediately after the addition of the 
enzyme fraction. Because the recovery of the added radioactiv!t"y 
was in the same range, whether or not enzymatic action had 
occurred, it appears that the methyl group at 020 was not split 
off during the metabolism of methyltestosterone. 
The information accumulated about the metabolite then 
indicates that it does not contain a ketone group or a ~4 or ~5 
'''v 
grouping. In all probability it has a saturated ring A, but it 
is not 17a-methylandrostane-3a,17~-diol because the two compounds 
move differently when they are chromatographed. It could be the 
3a isomer of methylandrostanedlo1, but since the 3a and 3~ 
isomers of methylandrostanediol did not behave differently during 
chromatography there is no reason to believe the anediols would. 
The most probable assumption is that the metabolite is one of the 
methyletiocholanediols. 
In addition to the major metabolite of methyltestosterone, 
which has just been discussed, at least two other radioactive 
areas were found. One of these was more polar than the major 
metabolite and less polar than corticosterone. When this sub-
stance was chromatographed on a more narrow lane, at least two 
compounds of very similar polarity appeared to be present. 
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These areas did not appear to absorb ultraviolet light when 
examined on the scanner. 
The other radioactive area had a polarity between that of 
corticosterone and that of cortisone. Because only one compact 
spot was detected on the chromatogram by analysis and by the 
color pl~duced with phosphomolybdic acid, this radioactive com-
pound appeared to be chrome.tographically pure. An examination 
of it on the Scanner showed it to absorb ultraviolet light. 
Table IV is a comparison of the Rf values of these metabo-
lites with corticosterone, cortisol, and cortisone. 
TABIE IV 
CONfPARISON OF SOME CORTICOIDS WITH METABOLITES OF 
17a-METHYLTESTOSTERONE-20-C14 
COMPOUND 
Metabolite (absorbing U. Vo light) 
Cor ti costerone 
Cortisol 
Cortisone 






Approximately 20 ~g. of each steroid was chromatographed. 
Cortisone and cortisol were put on the same 18 mm. lane. 
The paper strip was equilibrated for 16 hours and developed 
for 4 hours in the B-55 system. All Rf values were con-
verted from Rd values obtained. The metabolites were 
located by their radioactivity_ 
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Since the primary objective was the investigation of the 
major product of methyltestosterone metabolism in which the 
a-~ unsaturation of ring A was destroyed, and the enzyme system 
responsible for this destruction, the other metabolites were 
not investigated furthero 
IN SU~~ARYJ it appeared that the first major product 
accumulating in the metabolism of methyltestosterone by rat 
liver was a non-ketone alcohol with a saturated ring A. In 
view of the two groups on the molecule that need to be reduced 
in order for this condition to be achieved, it was probable 
that more than one enzyme was required in the conversion of 
methyltestosterone to the metabolite. The object of this 
investigation then became a determination of whether or not 
more than one enzyme was involved. 
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II. Cofactor Requirements: 
The enzyme catalyzing the formation of the metabolite from 
methyltestosterone was obtained in the soluble state. An active, 
clear, cherry-red solution was obtained when a homogenate of rat 
liver was centrifuged at 20,000 x g. and the supernatant was 
filtered through Celite. Table V, Experiment No.1, ,shows that 
the supernatant was slightly more active than the homogenate. 
In order to determine if the enzyme was present in the 
minute particles of the cell, the supernatant from the centri-
fugation at 20,000 x g. was recentrifuged at 100,000 x g. The 
results (Table V, Experiment No.2) indicate that all of the 
activity was in the soluble fraction. 
TABLE V 
METABOLISM OF 17a-METHYLTESTOSTERONE BY RAT LIVER FRACTIONS 
FRACTION 
Experiment No. l.~ 
Original homogenate 
Clear supernatant from 20,000 x g. Cent. 
Experiment No .. 2~;. 
Residue from the 100,000 x g. Cent. 
Supernatant from 100,000 x g. Cent. 
steroid Reduced 




0 .. 86 
~rOne micromole of ~ethyltestosterone was incubated per flask 
with the enzyme fraction for 1 hour at 36.5° C. The incuba-
tion medium contained Krebs phosphosaline buffer, pH 7.4+DPN. 
Each flask contained a final volume of 25 mI. An 02-C02 gas 
phase was used. 
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When the homogenate was prepared in the absence of niacina-
mide, the supernatant was completely inactive. An active super-
natant could also be inhibited considerably by dialyzing it 
against a large volume (12 liters) of phosphate buffero The 
loss of ei ther niacinamide or 'DPN was not responsi ole for this 
inhibition, because when they were added back, alone or in com-
bination, to the dialyzed medium they did not restore the 
activity. In one experiment, a combination of metal ions, in-
cluding O.OOIM FeC121 O.OOIM FeC13, O.OOIM ZnC12 " O.OOIM MnC121 
and O.OOlM CuCI2 , failed to restore activity. 
It was then found that a boiled extract of liver would 
restore the activity of the dialyzed enzyme fraction. Two 
preparations of boiled liver were compared. Fresh rat livers 
were cut into small squares and divided into two equal portions 
to each of which buffer was added. One portion was boiled and 
filtered to give a clear yellow filtrate while the other portion 
was boiled and homogenized. The results in Table VI indicate 
that the required cofactor or cofactors are not tightly bound to 
the liver tissue since the filtrate was as active as the whole 
liver preparationo When the liver was homogenized before it was 
boiled, the extra,ct was inactive, and activity was not restorted 
when niacinamide was added immediately after boiling. 
In view of the protection of the cofactors by niacinamide 
during homogenization, it was probable that the cofactor was 
one of the phosphopyridine nucleotideso DPN had already been 
shown to be inactive. In one experiment and with one incubation 
flask, TPN was also inacti vee When DPNH was incubated, it was 
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TABLE VI 




Dialyzed supernatant + boiled filtrate 
Dialyzed supernatant + boiled homogenate 
Steroid Reduced 
I:LM/ gm.. Ii ve r /hr. 
0.21 
Onemicromole of methyltestosterone was incubated per flask 
with the enzyme fraction for 1 hour at 36.5° C. The incuba-
tion medium contained Krebs phosphosaline buffer, pH 7.4+DPN. 
Each flask contained a final volume of 25 mI. An 02-C02 gas 
phase was used. 
found to be completely ineffective in restoring the activity in 
the presence of either an oxygen or nitrogen gas phase. It was 
then found that the activity of the enzyme could be restored by 
TPNH during incubation in a nitrogen gas phase. Later experi-
ments have shown that the enzyme is as active in the presence 
of NaH2Po4 + Na2HP04 pH 7.4 + TPNH as it is in the presence of 
the Krebs phosphosaline buffe~ descrtibed under Experimental 
Techniques, and boiled liver filtrate. An examination of the 
products of the incubation with TPNH as cofactor showed a com-
pound appearing which had the same characteristics as the major 
metabolite previously described. There were no compounds con-
taining ketone groups detectable with 2,4-dinitrophenylhydrazine, 
or A4 or A5-3-o1s detectable with phosphotungstic acid. 
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Therefore, TPNH was found to be the only cofactor required for 
the metabolism or ring A of methyltestosterone to a saturated 
alcohol. There was no evidence o£ significant accumulation of 
ketonic or unsaturated intermediates in this system. 
ITI. Enzyme Fractionation: 
1. First Ammonium Sulfate Fractionation: 
The supernatant from the centrifugation at 20,000 x g. was 
fractionated with ammonium sulfate. An amount of ammonium 
sulfate necessary to produce the desired concentration was 
added to the supernatant. After the precipitate which had 
formed was collected by centrifugation, it was dissolved in 
buffer and dialyzed against buffer or water. The dialyzed 
enzyme fraction was then incubated with methyltestosterone. 
Table VII, Experiment No.1, shows that the majority of 
activity was precipitated when the ammonium sulfate concentra-
tion was 60 per cent of saturation but not when it was 30 
per cent of saturation. 
Further fractionation revealed that most of the activity 
was precipitated at 50 per cent of saturation but not at 40 
per cent of saturation (Table VII, Experiment No.2). 
The product of incubation of methyltestosterone with this 
puriried enzyme fraction appeared to be the same as that iso-
lated from the homogenate incubations. It moved the same 
distance when it was chromatographed and gave a positive color 
reaction with phosphomolybdic acid. No evidence was found to 
indicate the presence of a ketone when the extract was 
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TABLE VII 
AMMONIUM SULFATE FRACTIONATION OF THE ENZYME 
FRAGTION 




















One mlcromole of methyltestosterone was incubated per flask 
with the enzyme fraction for 1 hour at 36.50 C. The incuba-
tion medium contained Krebs phosphosaline buffer, pH 7.4+DPN. 
Each flask contained a final volume of 25 mI. An 02-C02 gas 
phase was usedo 
chromatographed and t he strip sprayed wi th 2\,4-dini trophenyl-
hydrazineo There were also no detectable b,4 or f).5_3 - 0Is when 
the strip was sprayed with phosphotungstic acid. 
2. Calcium Phosphate Gel Fractionation: 
To a dialyzed solution of the material precipitating at 
50 per cent ammonium sulfate saturation, 25 mg. of calcium 
phosphate gel were added per mI. After the gel was blended with 
the solution, it was collected by centrifugation. To the super-
natant 50 mg. of the gel were then added per mlo and the blending 
and centrifugation were repeated. The protein that had been 
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adsorbed on the gel was eluted with OolM phosphate burrer~ 
pH 704. The amount of purirication and the units or enzyme 
present "in the fractions are presented in Table VIII. 
: . 
Elution of the enzyme adsorbed on the calcium phosphate 
gel wQs:!srried out at different pH's. Table VIII lists the 
pHRs used and the activity of the enzyme obtained. Since the 
best activity was obtained at pH 704 this was the pH that was 
used for elution in the remainder of the experiments. 
TABLE VIII 
CALCIUM PHOSPHATE GEL FRACTIONATION 
i"Total At· . t Total volume or enzyme solution 
c lV~ y Volume of solution required to reduce 1 ~go 
steroid. 
During this fractionation, the purification of the enzyme 
was 5 to 8-fold above that of the supernatant. However, the 
same metabolite that was formed by the annnonium sulfate fraction 
and the homogenate was produced, and no intermediates were 
found. 
3. Ethanolic Fractionation: 
The supernatant obtained from the adsorption on 25 mg. per 
mI. calcium phosphate gel was fractionated with cold ethanol. 
The precipitates that formed when the ethanolic concentrations 
were 20 per cent, 30 per cent, 40 per cent, and 50 per cent by 
volume were collected and incubated. In Table IX it can be 
seen that the greatest purification was found in the material 




25 mg. Ca3(P04)2 gel/mlo super. 















~}Total Activity= Total volume of enzyme solution 
Volume of solution required to reduce 1 ~g. 
steroid. 
tThese values were estimated from the amount of phosphomolyb-
dic acid color reduced. 
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When the products of the incubation with the fraction pre-
cipitated by 40 per cent ethanol were chromatographed, a spot 
which reacted with phosphomolybdic acid was found moving at the 
same rate as the major product from the homogenate incubation. 
No ketones were detected with 2,4-dinitrophenylhydrazine, and 
no ~4 or ~5-3-o1s were found with phosphotungstic acid. 
4. Second Ammonium Sulfate Fractionation: 
The material eluted from the precipitate after centrifuga-
tion of the 50 mg. per mI. calcium phosphate gel addition was 
fractionated with ammonium sulfate. Table X illustrates the 
fractions taken and the purification obtained. The only active 
portion was that precipitating at 60 per cent saturation. A 
small amount of purification resulted from this procedure and 
it is the most consistant one found so far. 
Here again no ketones or 44 or ~5-3-01s were detected in 
the extract from the incubation medium. The product that Was 
isolated had the same characteristics as that produced with 
the other fractions. 
During the fractionation of the liver preparation by the 
procedures just described, a certain amount of purification 
resulted. However, neither a sharp increase in activity 
ocourred, nor was Ghere any indioation that more than one enzyme 
was present. The same product was formed by all the enzyme 
fractions prepared and at the end of the inoubation there was 
an absenoe of any deteotable intermediates. 
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TABLE X 
SECOND AMMONIUM SULFATE FRACTIONATION 
FRACTION 
Steroid Reduced Total Activity ... 
~M/mg. N2 ~ge reduced/hr. 
__ --------------------------------+---~----------~~-- _____ L~ 
50 mgo Ca1(P04)2 gel/mle 
eluate (pH 704) 














i.Total Activity = Total volume of enzyme solution! 
Volume of solution required to reduce 1 p,.:g. 
steroid. 
IV. Attempts To Trap An Intermediate: 
Another approD.ch intended to indicate whether the reduc-
tion of ring A involved more than one stage and required more 
than one enzyme was' attemptedo It was postulated that by 
incubating a possible intermediate with radioactive testoster-
one which had been shown to be a substrate for the enzyme system 
(see Table XIII), the radioactivity would be trapped in the 
compound if the substance did indeed serve as product of one 
and substrate of a second enzyme •. Four micromoles of dihydro-
testosterone (DHT) were incubated in the presence of testosterone-
-60-
4_014 having a specific activity of 16,000 cpm per micromo1e. 
The specific activities of the major metabolite formed, and of 
the DHT isolated were then calculated and compared. From the 
results in Table XI it is apparent that the specific activity 
of the metabolite was about 10 times that of the DHT. Since 
there was some activity trapped in the DHT, the reduction must 
have taken place in at least two steps. The low specific 
activity of the DHT, however, would indicate that either it 
was not an intermediate on the main metabolic path, or that it 
was never completely free in the medium. 
TABIE XI 
SPECIFIC ACTIVITY OF INTERMEDIATE 
... -~ 
COMPOUND Specific Activity 
lJ-M CPM CPM/\J.M 
Metabolite 207 8812 3255 
DHT 1.5 533 355 
, 
A crude separation of the steroids from the incubation mix-
ture was made on a silica gel column. The fractions obtained 
were then chromatographed in the 0-85 system and the steroids 
separated and eluted. Quantitative estimation of DHT was 
made using the method of Gornall and MacDonald. The amount 
of metabolite was calculated from the amount of testosterone 
'and DHT destroyed. 
v. Effect of Different Buffers: 
To determine if phosphate ions were inhibiting the enzyme 
system, an incubation using phosphosaline, tris, and bicarbonate 
buffers was performed. The enzyme was active in both the Krebs 
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phosphosaline and Tris buffers. However, very little activity 
was shown in the Krebs-Ringer bicarbonate buffer. The ~M of 
steroid destroyed per gm. of liver per hour for each of the 







Because the bicarbonate buffer contained calcium ions and 
sulfate ions which were not present in the other buffers, it 
was postulated that either one or both of these ions might be 
inhibitory. \¥hen calcium ions were added to an incubation 
medium containing phosphate buffer, an inhibition was not 
observed (Table XII). The presence of versene during an 
incubation neither inhibited nor increased the enzymatic 
activity. No inhibition was detected when sulfate ions were 
added to the incubation. Therefore, the cause of the inhibition 
in the bicarbonate buffer remains undetermined. The values 
obtained also suggest that the activity of the enzyme may be 
greater in the Tris buffer than in the phosphate buffer. If 
any inhibition is caused by the phosphate ions, it is slight. 
VI. Inactivation of Enzyme: 
The enzyme was found to be fairly labile to standing, heat, 
and pH change. After standing in the refrigerator at 30 C. for 
two days, it had lost about 50 per cent of its activity. There 
did not seem to be any change in the rate of inactivation between 
the crude and more purified enzyme fractions. 
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When the enzyme was preincubated in the presence of air or 
oxygen for one hour at 36.50 C. it was completely destroyed. 
An atmosphere of nitrogen would preserve 81 per cent of the 
activity under the srune conditions. The enzyme was also de-
stroyed when it was heated in air to 600 C. for 4 minutes. 
The enzyme lost about 50 per cent of its activity when it 
was allowed to stand for 10 minutes at a pH of 5.8 and a tempera-
ture of 30 C. 
vrx. Inhibitors: 
A number of inhibitors which could contribute some informa-
tion about the site involved were incubated with methyltestoster-
one (Table XI.I)~. Cyanide was included to determine if the 
activity were dependent on the transfer of electrons to a 
V porprrin-bound iron ion. If iron ions were necessary and the 
activity depended on the oxidation and reduction of these ions, 
azide would inhibit by keeping the iron reduced to the ferrous 
state. The importance of sulfhydryl groups was determined by 
the effect of p-chloromercuribenzoate., Calcium ions were in-
cluded because of the inhibition found wi th the bicarbonate 
buffer, and the requirement for metals was determined with 
versene. 
It is apparent that the ,sulfhydryl group is required for 
activity. In view of this it is rather difficult to explain 
the inhibition of the cyanide since this ion has been shown to 
activate enzymes requiring the sulfhydryl groups. The only 
























TPNH was used as the cofactor, and N2 as the gas phase. > 
Otherwise, the cond-4,tions ')f incubatIon were the same as 
those listed under Table V. The enzyme fraction used was 
the 40 to 50 per cent ammonium sulfate cut from the super-
natant of a 100,000 x g. centrifugation. 
concentration used was, in some way, inhibitory. Because ver-
sene did not inhibit the enzyme it seems that no metal ions are 
required for activity. 
In view of the inhibition of the enzyme by p-chloromercuri-
benzoate, it was thought that cysteine might protect the enzymatic 
activity. Neither increased activity nor protection of the enzyme 
was found when it was present in a concentration of O.OOSM. 
VIII. Effect of Citrate: 
Citrate had been shown to activate the enzyme system that 
destroyed the a-~ unsaturation of ring A of both testosterone 
and methyltestosterone when they were incubated with liver slices 
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and homogenates (2){3). In these more purified enzyme 
fractions an activation by citrate was not observed. 
IX. Substrate Specificity: 
Table XIII shows the relative rates of reduction of a 
number of steroids containing the' A4-3-ketone grouping in ring 
A. It is apparent that the compound having the more polar 
group on the 17-position is the better substrate. The steree-
configuration of this group does not change the affinity of 
the enzyme for the substrate appreciably since the molecule 
having the 17n-hydroxyl group is almost as active as testoster-
one. The atomic constituents of this group do not decrease its 
substrate activity appreciably, as is shown by the comparative 
activi ties of the compounds having the 17-amino group and the 
17-hydroxy1 group. Although a substituted polar group on C-17 
increases the activity of the substrate it is not necessary 
since the compound having only hydrogen atoms at this position 
is still 60 per cent as active as one having maximum activity. 
Increasing the number of carbons on position 17 appears to 
decrease the steroid's effectiveness as a substrate. 17a-
methyltestosterone waR less active than testosterone but more 
active than progesterone or A4_pregnene-17f3-o1-3-one. 
X. Effect of Substrate Concentration: 
The dependence of enzymatic activity on substrate concen-
tration when an 02-C02 gas phase was present is shown in Figure 




SUBSTRATE Steroid Reduced Relative Rate \-LM/hr. of Reduction 
Testosterone 0.69 100 
Epitestosterone 0.66 96 
A4-androstene-17-amino-3-one 0.65 94 
" . 
A4-androstene-3,17-dione 0.56 81 
l7a-methyltestosterone 0.55 80 
Progesterone 0·44 64 
A4_pregnene-17f3'-ol-3 -one 0·42 62 
A4-androstene-3-one 0·40 60 
The amount of each steroid incubated was approximately 1 ~M 
per flask. A final volume of 20 ml. was incubated in each 
flask; otherwise the cohditions of incubation were the same 
as those listed under Table V. 
experiments wa.s employed. At this enzyme con'centration the 
Michaelis constant is approximately 1.65 x 10-5 M. 
When it was discovered that the enzyme was destroyed in an 
02-C02 gas phase, the incubation was again performed with N2 
(Figure 6). Under these conditions the rate is faster for a 
concentration of 2 micromoles than for 1. It also seems that 
a concentration of 3 micromo~sper 20 mI. inhibits the enzyme. 
If the straight line portion of the graph is extrapolated to 
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Substrate concentration (s) lJ.M/20 mI. solution 
Figure 5 - Plot of relative velocity against'substra.te 
concentration. Flasks were incubated for 1 hour at 36.50 c. 
with an 02-002 gas phase. The enzyme fraction used was 40 











(i) x 10-4 
Figure 6 - Plot of the reciprocal velocity against the 
reciprocal substrate concentration. The flasks were 
incubated for 1 hour at 36.50 c. with a ni trogen gas phase'. 
The enzyme fraction used was a 40 to 50 per cent ammonium 
sulfate cut. 
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XI. Effect of Length of Incubation: 
\Vhen the enzyme was incubated with methyltestosterone in 
the presence of an oxygen-carbon dioxide gas phase, the amount 
of the a-~ unsaturation destroyed was the same after 1 hour as 
it was after 3 hour~~. It Was then observed by preincubation 
for 1 hour that the enzyme was completely destroyed in an 
02-C02 gas phase. Therefore, the apparent equilibrium which 
had been reached after 1 hour was due to the destruction of the 
enzyme. When nitrogen, however, was used as the gas phase 
~ during incubation, an equilibrium was not reached at the end 
of 3 hours (Figure 7). It can also be se'en that the rate of 
reaction was slightly faster during the initial phase of the 
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Length of Incubation Time in Hours 
Figure 7 - ~M of steroid reduced as a function of timeo 
Methyltestosterone?was incubated at 36.5° c. in phosphosaline 
buffer pH 7.4 tmder a nitrogen gas ~hase. 
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XII. Effect of Incubation Temperat'ure: 
From an examination of Figure 8, it is apparent that two 
temperature optima have been found for the enzyme system destroy-
ing the a-~ unsaturation of ring A of methyltestosterone. One 
optimum appears at about 36.50 c. while the other optimum appears 
at approximately 500 c. 
An e~amination and comparison of the products of incubation 
formed from the 36.5°, 45°, and ,'50° C. incubations disclosed no 
difference in the products formed. No ketones were detected 
with 2,4-dinitrophenylhydrazine and no unsaturated 3-01s were 
detected with phosphotungstic acid. The amount of major product 
also appeared present in a quantity directly comparable to the 
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10 20 30 40 50 60 
Temperature of incubation in degrees C. 
Figure 8 - ~M of methyltestosterone reduced as a 
function of temperature. One ~M was incupated in a 
volume of 10 ml'. of phosphate buffer. The enzyme 
fraction used was a 40 to 50 per cent ammonium sulfate 
cut. A nitrogen atmosphere was used and the flasks 
were not rotated during incubation. The two optima were 
obtained in two separate experiments. 
XIII. Errect or pH: 
The effect of pH from 6.5 to 8.5 on the rate of the reaction 
was determined. Figure 9 shows a curve that appears to have two 
optima; one at 7.4 and another at 6.5 or lower. Almost the same 
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8.0 
pH 
Figure 9 - ~M of methyltestosterone reduced asa function 
of pH. The incubation was perrormed at 36.50 C. for 1 hour. 
XIV. Effect of Enzyme Concentration: 
Figure 10 shows the dependence of the rate of reaction on 
enzyme concentrationo It is surprising that no activity was 
found with 0.5 mI. or enzyme solution. Only one experiment 
of this type was performed. It then remains a question as to 
whether or not the absence of activity at this low concentration 
can be repeated. Ir this low value is discarded, a fairly good 
fit of a straight line that runs through the origin can be 
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mI. enzyme solution 
Figure 10 - ~LM of methyl testos te~one reduced e.s a 
function of enzyme concentration$ The incubation Vias 
per:formed at 36.50 c. for 1 hOU1~ under B ni trogen gas 
phase. The enzyme :fraction used was 40 to 50 per cent 
ammonium sulfate cut. 
xv. Incubation in the Presence of Tritiated Water: 
In order to see if the hydrogen ions that were transferred 
to the double bond and the 3 ketone group were donated by the 
f '. 
aqueous solution" tri tiated water' was added to the incubation 
medium. 17a-methyltestosterone and the majol" metaboli te were 
incubated wi th TPNH in a phosphosaline buf:fer containing 1 me. 
of tritiated water to which no enzyme had been added. This 
was done to determine if there were any eXChange of the hydrogen 
atoms of the steroid and the solution. Less than 2 cpm. per 
micromole was found in both compounds. It is, therefore, 
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apparent that there is a negligable amount of exchange between 
the hydrogen atoms of the steroid and those of the aqueous 
medium. When the metabolite which had been formed in the presence 
of tritiated water was ~nalyzed it contained 1494 disintegrations 
per minute. Calculation of the activity in the metabolite formed 
in the presence of tritium appears below: 
At a pH of 7.4, there would be a hydrogen ion 
4 -6 concentration of xlO moles per liter of water. 
-8 For a volume of 10 mI. there would be 4.0xlO moles 
of H+. The . amount of tritiated water added was 0.05 
mI. or 5xlO-3 of the total amount present, therefore, 
4.0XIO-8 x 5xlO-3 = 2.0xlO-lO of H+ contributed by the 
tritiated water. Since the tritiated water is composed 
of THO then 2xlO- lO = lxlO-lO moles of T+ present in 
2 
the incubation medium. One milicurie of tritium was 
present in 0.05 mI. of 2.8xlO-3 moles of water, therefore, 
the specific activity is 2.2XI09~ = 7.85xlOl1 disinte-
2.8xlO-..... 
grations per minute per mole of tritium. Since 1 
micromole of 17a-methyltestosterone had been incubated 
and 67 per cent of it had been reduced then 2.7xlO -6 
moles of H+' had been transferred to the steroid. The 
-
amount of tritium that would have been expected to be 
transferred was then lxlO-10 6 6 9 --~- x 2.7xlO- == .75xI0-
4xlO"8 
moles. Because the specific activity of the tritium 
was calculated to be 7.58xlOll disintegrations per 
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minute per mole and 6.75xIO-9 moles could be expected 
to transfer if all of the hydrogen ions were donated 
by the medium, the metabolite should contain 5.l,xl03 
disintegrations per minute. It appears that approxi-
mately 29 per cent of the hydrogen used for reduction 
is donated from the medium. 
DISCUSSION 
I. Structure of the Metaboli te Isolated: 
If one considers the possibilities of the structure of the 
major metabolite, assuming that the only change of methyltestos-
terone during the incubation is a reduction of ring A, the 
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The assumption that the only major change during metabolism 
is a reduction of ring A is not unlikely. Levedahl's (100) 
attempt to trap radioactivity in BaC03 when 17a-methyltestoster-
one-20-C14 was incubated with rat liver mince was unsuccessful. 
This finding has been confirmed in the present work because the 
same percentage of recovery of radioactivity was obtained from 
samples containing active enzyme as from those that had been 
boiled immediately after the addition of the enzyme. Since 
there is essentially no loss of radioactivity during the metabo-
lism, it is evident that the carbon at the 20 position is not 
lost. It is conceivable that there could be a rupture of one 
or more of the rings during metabolism. This, however, seems 
improbable because the metaboli te moves in the Bush chromatog-
raphy systems' at about the same rate as the inta.ct 17a-methyl-
ated steroids., If an opening of a ring had taken place, the 
material formed would not be expe,:}ted to move like a steroid. 
Therefore, the evidence is consistent with the assumption 
that the only change that takes place in the major metabolite 
when methyltestosterone is incubated is a reduction of ring A. 
A consideration of structures I end II has been made in 
this investigation. The compound r~presented by strpcture I 
was differentiated from the metabolite, after a series of in-
decisive experiments, by an Oppenauer oxidation and a fi"nal 
chromatographic separation during an extended period of 
development. The failure of the compound represented by 
structure II to recrystallize to a constant spectfic activity" 
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with the radioactive metabolite eliminates it as the possible 
structure. It then appears that the metabolite does not have 
the configuration of either structure I or II, even though both 
the free compounds and their acetates behaved in a manner chro-
matographically similar to the metabolite and its acetate. 
The compounds represented by structures ITI and IV have 
also been shown to be different from the metabolite. Neither 
a thiosemicarbazone nor a dinitrophenylhydrazone has been 
formed by the metabolite. With the concentrations of the 
metabolite used, a ketone group should have reacted with the 
reagent. Another steroid postulated on the metabolite, DHT, 
reacted when present in an equivalent concentration. There 
is no reason to believe that sterlc hinderance could explain 
the negative reactions of the metabolite provided it contained 
a ketone group. In addition, since a saturated compound having 
a ketone should be less polar than an unsaturated ketone, the 
metabolite, if it had a saturated ketone, would be expected to 
move between methyltestosterone and the front. This was in 
contrast to the results obtained because the metabolite moved 
between methyltestosterone and the origin. Therefore, the 
probability that the metabolite has either structure III or 
IV or even a ketone group on the molecule is ra.ther small. 
The compound having structure VII behaves differently 
from the metabolite when the two are chromatographed in the 
sa.me system. The metabolite, therefore, does not have 
struoture VII. 
A more tentative argument is used to ellrninc.te structure 
VIII. The only difference between structures VII and VIII is 
that VIr has the 3a while VIII has the 3~ configuration. When 
the 30: and 3f3 isom6l"s of 17a.-rnethYl-fl,4-androstenediol were 
chrornntographed, they behaved identically. Tt is assumed that 
the 3f3 and 3a isomers of the anediol would also behave simila:;..-;,ly. 
If this nssumption holda, then the metabolite could not have 
stl'ucture VIII either. 
The compounds '(lepresented by structures IX and X will be 
considered together. These structures also may be eliminated 
because when an OppenA,uer oxidation is performed on compounds 
of this structure they ape oxidized to a A4-3-ketone. Phospho-
tungstlc a.cid 9.1so reacts with these compounds to gi ve a purplish 
red color- Since the metabolite did not ~eac~ positively under 
the conditions necessary for the reactions to take place, it is 
evident thrlt it does not have oi ther structure IX or X. 
From an examination of the evidence in this investigation, 
tho metauoli te is an alcohol oeCB.use it will form an acetate. 
Due to tho similarity in the movements of the acetates of the 
17a-methyl-AL'-flndrostenediols and of the metabolite, it is ver'y 
probable that the metabolite is also a diol. 
The structures containing a ketone, ~nd those containing 
a double bond at either carbon atoms 4 or 5 have been eliminated 
from the list of suggested metabolites. In addition, evidence 
excluding the androstane nucleus (structures VIr and VIII) has 
been presented. Due to the process of elimination then, all of 
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the structures except V and VI have been discarded. At the 
present time there is no evidence against either of these 
structures. Therefore, the metabolite may be either the 3a 
or 3~ isomer of l7u-methyletiocholane-3,17~-diol. Since a 
synthesis of these compounds 'has not been reported, no com-
parison of characteristics could be made. 
II. Enzyme systems involved: 
'rh.:i:swork does not clearly indicate whether one or mor)e 
enzymes f:lre required for the reduction of the two groups in 
The lack of change in the chroma.tographic movement of 
the product produced by enzymatic action as more purified 
enzyme preparat16ns were used, and the absence of a saturated 
ketone or a a4 or A5 unsaturated 3-01, indicates that no 
separation of enzyme systems was achleved by any purification 
procedure used in this work. However, the radioactivity that 
was trapped in the DHT after an incubation of testo~terone-4c, 
c14 indicates that the major metaboli te 1s probably formed by 
a two-stage reaction. 
It vias Blso noted that not only did the DHT trap some of 
the r9.dioact1 vi ty but thB.t the amount of unche,nged r-adiol-!c ti ve 
testosterone remaining was larger when DHT was present. It 
appears, therefore, that DHT is competing with either testoster .... 
one or its intermediate for an enzymic site. If the competit:1.on 
were with the intermediate for sites on a second enzyme.g an 
acoumulation of the intermediate would be expected, as convex~sion 
of testosterone would only oe reduced by product inhibition. 
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Since the completely re~uced product appears to ae an 
etiocholanediol, the two possible intermedia tes would be 1;.4_ 
etiocholen-17~-ol-3-one or a4-etiocholene-3,l7-dione. There 
was no measurable radioactivity in the region where the latter 
conpound would chromatograph, but accumulation of the former 
could not be ruled out since, without overrunning, it could 
not be distinguished from the final product. The other 
possibility would be that the ~lT competed directly with 
testosterone for the original enzyme site, and that both 
reductions took place on the same enzyme. In this case, there 
would be no accumulation of intermediate. 
When the specific activity of DHT is compared with that 
of the major metabolite formed from the incubation of radio-
active testosterone, approximately 10 times as much is found 
in the metabolite. This situ.ation could be explained by 
assuming that both reductions are usually carried out before 
the product is relensed for the first time from the enzyme 
surface after the attachment of the substrate. Since the DHT 
is present in excess amounts, it could displace some of the 
Inbaled intermediate from the enzyme thereby leaving some 
radioactivity in the medium. By this mechanism a small amount 
of radioactivity would be found in the DHT while the majority 
of the radioactive molecules would be converted to the com-
pletely reduced product before they were released from the 
enzyme. Because there is no competition for the second stage 
of reduction when DHT is absent, a nondetectable amount of 
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intermediate would be all that is released into the medium. 
The trapped radioactivity in the DHT as well as the lack o~ 
formation of a radioactive intermediate in the absence of DHT 
can be explained by the above assumption. 
Another explanation for the greater activity in the 
ul tini.ate metaboli te is that DHT is not the rnaj or intermediate 
formed from testosterone. If the compound formed from testos-
terone has the 5~ rather than the 5, configuration, then it is 
probable thRt the 5[3 compound would be much the better substrate 
for the second enzyme. If this explanation is the right one, 
the ratio of molecules reduced would favor the ones having the 
.513 configuration; thus a higher specific activity would be 
found in the major metabolite. 
The evidence is more in favor of a two enzyme catalyzed 
reduction. However, there is no evidence that cannot also be 
explained so that it will apply to a one-enzyme catalyzed Te-
duction. While there is no precedent established indicating 
thut one enzyme is capable of catalyzing the reduction of a 
ketone group and Fi double bond, some enzyme preparations, 
thought to contain a single component" catalyze binary re-
actions. Talalay (lOl)'has isolated a bacterial enzyme that 
'Nill reduce the ketone groups on both C3 and C17 of u
4
-andro-
stene-3,17-dione. Phosphoglyceric aldehyde dehydrogenase ~ill 
oxidize the B,ldehyde group to the acid as well 8$ form an 
ester with phosph8.te. Both the C-N nnd the C-O bond can be 
hydrolyzed by carboxypeptidase. The enzyme investigated here 
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may also catelyze a binary reduction or a technique capable of 
separating the enzyme :system into more than one component may 
not have been used. 
The occurrence of two temperature optima a~so points toward 
a two stage system. If, however, the product of one reaction 
were the obligatory substrate for the other reduction" an accumu-
lation of this intermediate would have been expected at one or 
the other temperature optimum. Although the reduction of methyl-
testosterone at either optimum was 0.2 micromole or more per 
flask, no evidence of the presence of an unsaturated diol or of 
a satura~ed dione could be found; only the spot acting like a 
saturat~d diol was present. If the two temperature optima are 
associHted directly wi th the two steps in reduction of the 
steroid, either reaction would appear to occur independently 
of the other, and the capacity of both systems must be adequate 
to carry out the second reduction of either intermediate. 
Since, however, the enzyme systems used in the temperature 
studies. were not pure, and the source of cofactor was boiled 
liver extIlAct, it may be that one temperature optimum is that 
of an enzyme involved in the production of DPrm or TPNH, and 
that the concentration of cofactor became limiting at certain 
temperatures. In this case" one. could assume that both re-
ductions are taking place at the same enzyme site. 
The enzyme systems studied here may be similar to those 
described by Tomkins (85) which catalyze a reduction of ring 
A of the corticosteroids. He claims to have separated his 
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system into two components. One initially reduces the double 
bond and the other reduces the 3-ketone group_ He has been able 
to accomplish this separation by calcium phospha.te gel adsorption. 
Contrary to his results, no indication of a separation of the 
enzyme system responsible for the saturation of ring A of methyl-
testosterone or testosterone was achieved in this work when 
calcium phosphate gel adsorption was employed. This discrepancy 
may be the result of differences between calcium phosphate gel 
preparations in mixing, aging, or other factors involved, since 
there is evidence that calcium phosphate gel is sometimes erratic. 
If two enzymes were necessary for the production of a 
saturated ring A alcohol, then some enrichment of one of the 
enz.ymes over that of the other would have been expected during 
the purification procedure. No evidence of this was found. 
~ome chRnge in the ratio of the activities of the two enzymes 
could ha 1/e been obtained and still been undetect'ed, prov:tded 
the second enzyme was more active than the first one. This 
situation would account for the failu~e to detect any intermedi-
nte as long DS the second enzyme was present in sufficient 
amounts to catalyze almost completely the reduction of the 
intermedi£:"te formed. In this CR.se there would ulways be an 
undetocte.hle amount of intermedia:te present. r:lhe 3a-hydroxy-
steroid dehydrogenase described by Tomkins (86) was shown to 
be more active than the enzyme catalyzing the reduction of the 
double bond. If the enzymes under investigation exhibit the 
same chA.racteristics, then an enrichment of one enzyme could 
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h.'lve taken place wi thout detection. 
The only cofactor shown to be necessary for the complete 
saturation of ring A is TPNH. If two enzymes are necessary for 
the reduction then both of them must be able to use TPNH. 
Tomkins (85) hp.s found that TPNH is the only cofactor t hat will 
function in the reduction of the double bond but that either 
Tl)HH or DP~HI will act VIi th his 3a-hydroxysteroid dehydrogenase. 
It may be that the same arrangement applies to this system. 
The evidence of this investigation does not decisively 
indicate whether the enzyme system studied in this work is 
s tmilB.r to, tho same as, or a different system from that 
described by Tomkins (85) although certain similarities of 
the two h9.ve been mentioned. 
In vievf of the inhibition found when p-chloromercuribenzo-
ate Via.S present" and the destruction of enzymatic activi ty during 
incubation in an 02-C02 atmosphere, it seems probable that one 
enzyme site has Hn essential -SH group. It is rather unusual" 
therefore, th~lt no activation or protection of the enzyme was 
found in the prcnence of cysteine. However, some investigators 
(102) were only nble to show a cysteine activation or protection 
of lln enzyme which had been highly purified. It may well be 
that this enzyme has not been obta d in a state purifica.-
tion high enough for this effect to be noticed. Otherwise" no 
reason has been found to explain the ineffectiveness of cysteine 
in this respect. 
It is ruther enticing to speculate on the structure of the 
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substrate required for attachment to the enzyme catalyzing the 
first step. The results from the study of various steroids 
indicates that a substituted 17 position increases the affinity 
of the enzyme for the subst~ate. However, the relatively high 
activity of the compound 44-~ndrostene-3-one having no sub-
stituted group on the 17 position, indicates that this point 
of attachment is not of great importance. Since the methyl 
groups at positions 10 and 13 both are sterically situated on 
one side of the steroid nucleus these groups may play a major 
role in the binding of the substrate to the enzyme. Whether 
any configuration of the steroid other than the A4-3-ketone 
grouping of ring A is important for the enzymatic reactions 
can be only speculated on at the present time. 
It appears that approximately one-fourth of the hydrogens 
transferred to the steroid molecule on reduction of the A ring 
are donated by the medium. \Vhether or not this is an obligatory 
condition cannot be elucidated from the information obtained in 
this investigation. Loewus et ale (103)· have shown that the 
deuterium from the medium is transferred to the malate during 
the reduction of oxalacetate if the oxalacetate is in the enol 
form. In contrast to this, they concluded that all of the 
hydrogens transferred to the keto form were donated by DPNH. 
Since approximately one-fourth of the hydrogens acquired are 
donated by the medium to the steroid when testosterone is 
reduced in the system studied here, it is not unlikely in view 
of the results of Loewus et ale that the two hydrogens required 
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to reduce the ketone group and one of the hydrogens necessary 
to reduce the double bond are donated by TPNH. As a result, 
a strong nucleophilic center would exist around the other 
carbon atom. Hydrogen ions from the medium would then be 
attr3cted to this center and attached to the carbon. This 
mechanism would account for the results obtained. 
Another explanation, however, may be offered for these 
resultso Talalay et al. (104) found a transfer of deuterium 
from the medium of testosterone when d4-androstene-3,17-dione 
was reduced by a bacterial enzyme requiring DPNH. "This trans-
fer was apparent only when a fairly crude enzyme preparation 
was used. When a more highly purified enzyme was employed all 
of the hydrogens transferred to the steroid were donated by 
the DPNH. An explanation for this finding was not offered. 
It may be, therefore, that the same mechanism may apply to 
this work and that a more purified enzyme would transfer the 
hydrogens ~olely from TPNH to the steroid. 
IN SUMMARY, it may be stated that rat liver contains an 
enzyme system which red~ces the 44'-3-ketone group in ring A 
of l7a-methyltestosterone and other C19 and 021 steroids 
forming a product that probably has the 5~-configuratiQn. 
This reduction is probably carried out in two stages. The 
first stage appears to be a reduction of the double bond, 
since DHT acts as' a competitive substrate for the second stage 
of the transformation. Since no intermediate products have 
been isolated during incubation with any enzyme fraction used, 
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it appears that the second stage is much more active than the 
first. Because TPNH is the only required cofactor that has 
been found, both enzymes, if two are required, must be able to 
use it. The enzyme catalyzing the first stage also appears to 
have a sulfhydryl grouping which is necessary for enzymatic 
activi ty. At the present stage of purifics.tion some of the 
hydrogens used to reduce the steroid A ring are donated by the 
medium. The probability remains that this system may be the 
same as that studied by Tomkins. 
SUMMARY 
Methyltestosterone has been incubated with rat liver 
preparations. The metabolite found in the largest concen-
tration was more polar than l7a-methyltestosterone. It was 
radioactive when l7a-methyltestosterone-20-C14 was incubated. 
No double bond OIl ketone groups have been demonstrated on the 
molecule. The steroid was capable of forming acetates indioat-
ing it was an a.lcohol. Essentially no radioa.ctivity was lost 
during incubation which implies that the methyl group at 
position 20 was not lost during metabolism. This metabolite 
moved different from l7a-methyla.ndroste.ne-3a,17~-diol during 
chromatography. By the process of elimination of the possible 
reduced compounds, the metabolite was tentatively identified 
as either the 3a or the 3~ isomer~ of 17a-methyletiocholane-
diol. 
Other radioactive substances have been isolated when 
17a .. methyltestosterone·-20-c14 was incubated. These substances 
have a polarity similar to that of the corticosteroids. Fur-
ther identification has not been carried out on these metabolites. 
The enzyme or enzymes responsible for the reduotion of ring 
A have been found in the supernatant solution from 100,000 x g. 
centrif~gation. The only cofactor which had been demonstrated 
to be required for complete saturation of ring A was TPNH. 
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Attempted purification of the enzymes has been tried by 
using e.mmonium sulfate fractionation, calcium phosphate gel 
adsorption, ethanol fractionation at reduced temperatures, and 
a second ammonium sulfate fractionation. Although an increased 
qupnti ty of steroid reduced per mg. of ni trogen incubated was 
found during purification, no evidence of a separation of the 
enzyme systems was indicated. The major product isolated from 
all of the fractionation procedures by chromatography appeared 
to have the same characteristics. No evidence of an intermediate 
ketone or lJ+ or 1:l5 -3-01 was found. 
The enzyme was found to be fairly labile to a change of 
time, tempereture .. and pH. 
p-chloromercuribenzoate completely inhibited enzymatic 
activitye A.pproximately 50 per cent inhibition by KeN was 
found 'VIi th the high concentrations used. 
Although a sulfhydryl group seemed to be involved, no 
pctivation 01') protection of, the enzyme was found in the presence 
of O.005M cysteine. 
A number of steroids having a A4-3-ketone grouping in ring 
A and having different groups on position 17 were found to be 
substrates of the enzyme. Testosterone was shown to be the 
most active substrate of those that were used. 
Some radioaotivity was found in the d1hydrotestosterone 
isolated when testosterone-4-c14 was incubated in the presenoe 
of dihydrotestosterone. However, its specific activity was 
about one-tenth of that of the major metabolite. 
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Kinetic measurements of the enzyme fraction obtained at 
50 per cent of ammonium sulfate saturation but not at 40 per 
cent show two temperature optima and indicate two pH optima. 
The calculated Km was 2.64 x 10-5 M. 
By the use of tritiated water, it appears that approximately 
one-fourth of the hydrogen ions required for the reduction of 
the double bond and ketone group in ring A are donated by the 
medium at this sts,ge of enzyme purification. 
Whether or not one or more enzymes are required for the 
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